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Abstract
The assembly of soluble proteins into ordered fibrillar aggregates with cross-b structure is an essential event of many
human diseases. The polypeptides undergoing aggregation are generally small in size. To explore if the small size is a
primary determinant for the formation of amyloids under pathological conditions we have created two databases of
proteins, forming amyloid-related and non-amyloid deposits in human diseases, respectively. The size distributions of the
two protein populations are well separated, with the systems forming non-amyloid deposits appearing significantly larger.
We have then investigated the propensity of the 486-residue hexokinase-B from Saccharomyces cerevisiae (YHKB) to form
amyloid-like fibrils in vitro. This size is intermediate between the size distributions of amyloid and non-amyloid forming
proteins. Aggregation was induced under conditions known to be most effective for amyloid formation by normally
globular proteins: (i) low pH with salts, (ii) pH 5.5 with trifluoroethanol. In both situations YHKB aggregated very rapidly into
species with significant b-sheet structure, as detected using circular dichroism and X-ray diffraction, but a weak Thioflavin T
and Congo red binding. Moreover, atomic force microscopy indicated a morphology distinct from typical amyloid fibrils.
Both types of aggregates were cytotoxic to human neuroblastoma cells, as indicated by the MTT assay. This analysis
indicates that large proteins have a high tendency to form toxic aggregates, but low propensity to form regular amyloid in
vivo and that such a behavior is intrinsically determined by the size of the protein, as suggested by the in vitro analysis of
our sample protein.
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Introduction
A large family of human pathologies is associated with the
conversion of peptides and proteins from their soluble functional
forms into well-defined fibrillar aggregates, often called amyloid
fibrils when they accumulate in the extracellular space [1]. Such
diseases include neurodegenerative disorders, such as Alzheimer’s
disease and spongiform encephalopathies, non neuropathic local-
ized amyloidoses, such as type II diabetes and atrial amyloidosis and
non neuropathic systemic amyloidoses, like light-chain amyloidosis
and dialysis-related amyloidosis [1]. Images acquired by transmis-
sion electron microscopy show that amyloid fibrils are long, rigid,
unbranched and usually consist of a number (typically 2–6) of
protofilaments, each about 2–5 nm in diameter [2]. These
protofilaments twist together to form rope-like fibrils that are
typically 7–13 nm wide [2,3] or associate laterally to form long
ribbons that are 2–5 nm thick and up to 30 nm wide [4,5]. The
fibrils have the ability to bind specific dyes such as thioflavin T (ThT)
and Congo red (CR) [6] and are characterized by an extended cross-
b structure, as revealed by X-ray fiber diffraction [3].
The peptides and proteins that form extracellular amyloid fibrils,
or intracellular inclusions with recognized related morphological
and structural characteristics, are generally small in size, often
shorter than 250 residues [1]. Even proteins that have been
converted into amyloid-like fibrils in vitro and have no link to human
diseases are generally small, typically shorter than 150 residues
[7,8]. The small percentage of large proteins recognized to form
amyloid or amyloid-like fibrils is disproportionate to the fraction of
such proteins in the human proteome, as more than 50% of natural
human proteins are longer than 250 residues. The question thus
arises as to why diseases associated with amyloid or amyloid-like
deposits do not generally arise from large proteins.
To address this issue we have carried out an extensive search in
the literature of all proteins recognized to form deposits distinct
from amyloid under pathological conditions and have compared
the sizes of such proteins with those known to form amyloid
deposits in disease. We will show that the size distributions of
proteins forming amyloid and non-amyloid deposits in pathology
are well separated and that proteins associated with non-amyloid
deposits are remarkably longer. We have then investigated the
aggregation process in vitro of a fairly large model protein, namely
the 486-residue (55 kDa) protein hexokinase-B from the yeast
Saccharomyces cerevisiae (YHKB). The size of this protein falls within
the region of overlap of the size distributions of amyloid and
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non-amyloid forming proteins. In particular, we have determined
the type of protein aggregates formed by such protein under two
sets of conditions, both shown to be among the most effective in
promoting amyloid fibril formation in vitro [9–23]. Using different
biophysical techniques we will show that both conditions promote
the very rapid formation of aggregates, characterized by significant
b-sheet structure but only weak ability to bind ThT and CR and a
morphology different from that of regular amyloid fibrils.
Importantly, however, we will also show that both types of
aggregates appear to be toxic to cultured cells.
The results indicate that large proteins have a great tendency to
aggregate into deleterious species but a poor propensity to form
real amyloid fibrils and suggest that the difference in behavior
between proteins forming amyloid structures and proteins
producing non-amyloid deposits in pathology is primarily and
intrinsically determined by the length of the polypeptide chain
undergoing aggregation.
Materials and Methods
Materials
8-anilinonaphthalene-1-sulfonate (ANS), trifluoroethanol (TFE),
trifluoroacetic acid (TFA), ThT, CR and a-cyclodextrin were
purchased from Sigma-Aldrich (St. Louis, MO, USA). YHKB was
also obtained from Sigma-Aldrich as a crystalline suspension in
ammonium sulfate (code H6380). After re-suspension of the
enzyme in the buffer used in the reaction medium, it was dialyzed
at 4uC for 24 hours and then filtered with a 20-nm syringe filter
(Whatman, Maidstone, UK). Protein concentration was deter-
mined by absorbance measurements at 280 nm, using an
extinction coefficient (e1%) of 9.47 [24]. Far-UV circular dichroism
(CD) analysis confirmed the native structure of the protein.
Dynamic light scattering measurements carried out with a
Malvern Zetasizer Nano S instrument (Malvern, Worcestershire,
UK) confirmed the absence of large aggregates in the sample.
Far-UV CD
Far-UV CD spectra of native and acid-unfolded YHKB, both in
their monomeric forms, were acquired in 50 mM phosphate
buffer, pH 7.0 and in 20 mM TFA, pH 1.7, respectively. For the
pH titration spectra were acquired in 20 mM glycine-HCl,
20 mM acetate; 20 mM N-(2-Hydroxyethyl)piperazine-N’-(2-
ethanesulfonic acid) (HEPES); 20 mM Tris. For the TFE titration
spectra were acquired in 50 mM acetate buffer, pH 5.5, and
various TFE concentrations ranging from 0 to 45% (v/v), with and
without 1 mM a-cyclodextrin. Far-UV CD spectra during
aggregation were acquired in 20 mM TFA, 360 mM NaCl,
pH 1.7 (first explored conditions) and in 50 mM acetate buffer,
pH 5.5, 30% (v/v) TFE (second explored conditions) at various
time points. Spectra were also recorded in 20 mM TFA, pH 1.7 at
various NaCl concentrations ranging from 30 to 810 mM. In all
these experiments YHKB was diluted to a final concentration of
0.1 mg/ml and the spectra were recorded at 25uC using a 1-mm
path-length cell and a Jasco J-810 spectropolarimeter (Tokyo,
Japan) equipped with a thermostated cell holder connected to a
Thermo Haake C25P water bath (Karlsruhe, Germany).
Intrinsic fluorescence spectroscopy
pH titration and TFE titration were also followed by recording
fluorescence spectra of YHKB, at a concentration of 0.025 mg/
ml, in the conditions described above for far-UV CD. The spectra
were recorded at 25uC using a Perkin-Elmer LS 55 spectrofluo-
rimeter (Wellesley, MA) equipped with a thermostated cell holder
attached to a Haake F8 water bath (Karsruhe, Germany). A
2610 mm path-length quartz cell and an excitation wavelength of
280 nm were used.
ThT assay
YHKB was incubated at 25uC, at a protein concentration of
0.1 mg/ml, in (a) 20 mM TFA, pH 1.7, 25uC and NaCl at
concentrations ranging from 30 to 810 mM and (b) 50 mM
acetate buffer, pH 5.5, 30% (v/v) TFE, 25uC. At different time
points, 60 ml aliquots of each sample were mixed with 440 ml of a
solution containing 25 mM ThT, 25 mM sodium phosphate
buffer, pH 6.0, 25uC. The fluorescence emission spectra were
recorded at 25uC using an excitation of 440 nm and the
instrument described above. All spectra are reported after
subtracting the spectra recorded for ThT in the absence of
protein from those recorded in its presence.
CR assay
Samples were prepared similarly to the ThT experiments
described above. At different time intervals, 60 ml aliquots of each
sample were mixed with 440 ml of a solution containing 20 mM
CR, 5 mM sodium phosphate buffer, 150 mM NaCl, pH 7.4,
25uC. Optical absorption spectra were acquired from 400 to
700 nm, after a two to three minute equilibration at 25uC, using a
5 mm path-length cell and a Jasco V-630 UV-visible spectropho-
tometer (Tokyo, Japan). In each case, the difference spectrum was
obtained by subtracting the spectra acquired for the protein alone
and for CR alone from the spectrum recorded for the protein in
the presence of CR.
Tapping-mode atomic force microscopy (TM-AFM)
Aliquots of YHKB at a concentration of 0.1 mg/ml in 30% (v/v)
TFE, 50 mM acetate buffer, pH 5.5, were withdrawn at different
aggregation times and diluted 5 times with milliQ water. 20 ml of the
diluted samples were deposited on a freshly cleaved mica substrate
and dried under vacuum. 20 ml aliquots of YHKB at a
concentration of 0.1 mg/ml in 360 mM NaCl, 20 mM TFA,
pH 1.7 were withdrawn at different aggregation times, deposited for
5 minutes on a freshly cleaved mica substrate, washed with milliQ
water and dried under vacuum. TM-AFM images were acquired in
air using a Dimension 3000 microscope (Digital Instruments–
Veeco, Santa Barbara, CA), equipped with a ‘G’ scanning head
(maximum scan size 100 mm) and driven by a Nanoscope IIIa
controller. Single beam uncoated silicon cantilevers (type OMCL-
AC160TS, Olympus, Japan) were used. The drive frequency was
between 341 and 342 kHz. The scan rate was between 0.6 and
1.0 Hz. Aggregate sizes were measured from the height in cross
section of the topographic AFM images. To take into account the
reduction in size with respect to fully hydrated conditions caused by
the drying procedure, the aggregate heights reported in the Results
were obtained multiplying the measured heights by a shrinking
factor of 2.2, evaluated by comparing the heights of a globular
protein under liquid and in air after drying under vacuum.
X-ray fiber diffraction
YHKB aggregates grown for 2 hours at a concentration of
0.1 mg/ml in a solution containing 30% (v/v) TFE, 50 mM acetate
buffer, pH 5.5, were centrifuged (3500 rpm, 21uC) for 10 minutes.
The resulting pellet was collected and inserted in a 0.7 mm capillary
with an open end. The capillary was then inserted into an expanded
polystyrene support to avoid its rupture and gently centrifuged.
After removal of the supernatant the pellet was exposed to air for
about 1 week. The capillary was exposed to X-rays at room
temperature using synchrotron radiation at beamline ID14-4
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(ESRF, Grenoble). Analysis of fibre diffraction images and estimate
of spacings was achieved using the program Mosflm [25].
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) reduction test
Human neuroblastoma cells (SH-SY5Y) (A.T.C.C., Manassas,
VA) were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) F-12 Ham with 25 mM HEPES and NaHCO3 (1:1)
supplemented with 10% fetal bovine serum (Sigma-Aldrich),
1.0 mM glutamine and antibiotics. Cells were maintained in a
5.0% CO2 humidified atmosphere at 37uC and grown until 80%
confluence for a maximum of 20 passages. YHKB samples were
prepared similarly to the ThT experiments described above. At
various time intervals aliquots were centrifuged, dried under N2 to
remove TFE or TFA when necessary, dissolved in DMEM without
phenol red, and immediately added to SH-SY5Y cell culture
media for 24 h at a final YHKB concentration of 2 mM. Aggregate
cytotoxicity was assessed in 96-well plates by the MTT assay
(Sigma, Milan, Italy), as previously reported [26]. Briefly, after the
exposure to 2 mM YHKB aggregates for 24 h at 37uC, the cell
cultures were incubated with 0.5 mg/ml MTT solution at 37uC
for 4 h and with cell lysis buffer (20% SDS, 50% N,N-
dimethylformamide, pH 4.7) for 3 hours. Absorbance values of
blue formazan were determined at 590 nm. Cell viability was
expressed as percent of MTT reduction in treated cells as
compared to cognate untreated cells.
Results
Proteins forming amyloid deposits are smaller than those
forming non-amyloid deposits
We have collected two databases of peptides or proteins
reported to form proteinaceous deposits in pathology. The first
database includes 25 peptides and proteins reported to form either
extracellular amyloid fibrils or intracellular inclusions with
morphological and structural amyloid-like characteristics in
human pathology. The second includes 9 systems found to form
deposits with characteristics distinct from amyloid in disease.
Assignment to either group was based on reported evidence on the
amyloid or non-amyloid nature of the deposits, as detected using
electron microscopy and/or CR staining. Only proteins for which
such evidence has been reported have been included in the two
databases. Proteins shown to form amyloid-like fibrils only in vitro
in the absence of a characterization of their amyloid morphology
in vivo have been excluded from the analysis (these include a-
synuclein, superoxide dismutase, many poly-Q containing pro-
teins). Huntingtin fragments, recognized to form amyloid-like
inclusions, have also been excluded from the analysis due to severe
uncertainty in determining the length of the fragments [27,28]
The two databases, listing the names of the proteins, their sizes,
their associated pathologies and references are reported in Tables
S1 and S2, respectively (see supplementary information on-line).
Fig. 1 shows the sizes, reported as the logarithm of the number
of amino acid residues, of all the proteins belonging to the first and
second group. The size distributions of the two groups of proteins
appear to be well separated (Fig. 1). The proteins reported to form
non-amyloid deposits are, on average, bigger in size, with lengths
ranging from 345 to a few thousands of residues (Fig. 1, Table S2).
By contrast, amyloid-forming proteins are typically smaller than
250 residues, with tau and lactoferrin representing the only
exceptions in a group of 25 cases (Fig. 1, Table S1). The size
distributions of the two populations of proteins are significantly
different (p,0.001).
In our analysis the immunoglobulin light chain has been
assigned to the group of amyloid-forming proteins because of the
prevalence of light chain amyloidosis with respect to light chain
deposition disease. Along the same lines, the immunoglobulin
heavy chain has been assigned to the non-amyloid database, due
to the prevalence of heavy chain deposition disease with respect to
heavy chain amyloidosis. Serpins and hemoglobin, which are
associated with serpinopathies and cell sickle anemia, respectively,
have been excluded from the analysis because they both form
fibrillar aggregates that are distinct from amyloid, yet highly
structured. Remarkably, however, the addition of hemoglobin and
serpin to either database, and the concomitant transfer of the
immunoglobulin light chain and heavy chain from their currently
assigned databases to the other, does not compromise the
statistical significance of the difference observed for the two
groups of proteins (p,0.01 in all cases). This highlights the
robustness of the statistical analysis and indicates that the observed
difference between the two groups of proteins does not depend on
the assignment of these few ‘‘ambiguous’’ cases.
YHKB converts into a partially unfolded, potentially
amyloidogenic state at low Ph
We then investigated the aggregation process in vitro of the 486-
residue YHKB. The size of this protein falls within the region of
overlap of the size distributions of proteins forming amyloid and
non-amyloid deposits in pathology [log(486) = 2.68]. YHKB was
used as a sample protein. The study of this protein was not aimed at
demonstrating that none of the large proteins forms amyloid-like
fibrils, but at investigating the behavior of an intermediate size
Figure 1. Size distributions of proteins reported to form non-
amyloid deposits in human pathology (left) and of proteins
described to form extracellular amyloid fibrils or intracellular
inclusions with amyloid-like characteristics in human disease
(right). Each data point represents one peptide or protein with its size
described as a logarithm of the number of amino acid residues (y axis).
A list of all the proteins reported in the graph and of their sizes is shown
in Tables S1 and S2. The scatter of data points on the x axis has no
meaning and it has been introduced to separate the data points in the
graph. The horizontal and vertical lines indicate the mean values and
the associated standard deviations for both populations. The size
distributions are significantly different (p,0.001).
doi:10.1371/journal.pone.0016075.g001
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protein under conditions known to lead to amyloid fibril formation
in vitro. We first determined whether this protein forms amyloid-like
fibrils under conditions of low pH in the presence of salts, which are
known to be effective in promoting amyloid formation not just from
proteins normally associated with amyloid diseases [13–16,18], but
also from proteins with no link to disease [9,11,17,20–22].
Amyloid fibril formation by globular proteins generally requires
the presence of a partially unfolded state [8,29]. Intrinsic
fluorescence and far-UV CD spectroscopy were used to monitor
possible conformational changes of the protein as the pH is
decreased from neutral to acid values in the absence of salts. Both
spectroscopic probes monitored substantial changes as the pH is
reduced from 4 to 3, with a single sharp transition (Fig. 2A). The
pH dependence of ANS fluorescence also showed a similar
transition within the same pH range (data not shown). The
spectral diagram reporting intrinsic fluorescence at 340 nm (F340)
versus the mean residue ellipticity at 222 nm ([h]222) possesses only
one linear part (Fig. 2B). This indicates the existence of one
transition in the pH titration of the enzyme and suggests that a
two-state model is a good approximation to describe the pH
unfolding of the enzyme under the investigated pH range.
A comparison between the far-UV CD spectra acquired at
pH 7.0 and 1.7 in the absence of salts indicated a significant
conformational change following the pH decrease (Fig. 3).
However, it is clear that the CD spectrum of the pH-denatured
state is not typical of a fully unfolded state and rather indicates the
persistence of significant secondary structure (Fig. 3). Overall, the
pH-denatured state of YHKB is a partially unfolded state and thus
a good candidate for amyloid fibril formation by this enzyme.
Acid-denatured YHKB converts into aggregates with b-
sheet structure, weak ThT- and CR-binding
Addition of salts to samples containing proteins denatured at low
pH is known to accelerate aggregation dramatically [30,31]. Hence,
to assess whether the acid-denatured state of YHKB is amyloido-
genic, YHKB was incubated in 20 mM TFA, pH 1.7, in the
presence of various concentrations of NaCl ranging from 360 to
810 mM. The far-UV CD spectrum acquired after 5 minute
incubation at pH 1.7 with 360 mM NaCl showed subtle, yet
significant, changes with respect to that acquired before salt addition
(Fig. 3). The change became more and more apparent with time
and the spectrum acquired under the same conditions after 2 hours
contained a low CD signal and a major negative peak in the 220–
230 nm region (Fig. 3). Despite this peak being red-shifted with
respect to the canonical b-sheet profile, such a feature is typical of
large aggregates containing b-sheet structure [12,32,33]. The red-
shift of the peak wavelength and the decrease of signal intensity arise
from the differential absorption flattening effect arising from heteroge-
neous samples in which solid state material is suspended in solution
[34]. Overall, the far-UV CD analysis indicated the presence of b-
structured aggregates at early time points following incubation
under the conditions employed here. Similar results were obtained
for higher NaCl concentrations investigated, such as 540 and
810 mM, with the rate of formation of b-structured aggregates
increasing with NaCl concentration (data not shown).
Protein samples incubated for various lengths of time at pH 1.7 in
the presence of 360 mM NaCl were also analyzed using the ThT
fluorescence and the CR optical absorption assays. ThT is widely
used as a marker of amyloid fibril formation in vitro, manifesting a
strong increase in fluorescence intensity in the presence of amyloid
fibrils [6]. The fluorescence emission spectra of ThT, obtained after
the addition of YHKB pre-incubated for 5, 30, 60 and 120 minutes
under these conditions, featured a weak, albeit significant, increase
of fluorescence with respect to those obtained from either ThT
alone or ThT in the presence of the native protein (Fig. 4A).
CR is also widely used to reveal the presence of amyloid fibrils.
It binds to the fibrils with its absorption maximum shifting from
490 to 540 nm [6]. The difference spectra of CR obtained using the
protein samples after 5, 30, 60 and 120 minutes of pre-incubation
showed a maximum at ca. 540 nm (Fig. 4B). The height of the
peak in the difference spectrum was significantly higher than that
obtained using the native protein, indicating formation of
aggregates (Fig. 4B). In both ThT and CR assays the maximum
effect was obtained after 30–60 minutes.
The aggregates formed by YHKB at low pH appear to be
morphologically amorphous
The YHKB samples aged at pH 1.7 in 360 mM NaCl were also
analyzed using TM-AFM. The aggregates appeared to be
Figure 2. H-induced unfolding of YHKB. (A) pH-induced unfolding
of YHKB monitored by the fluorescence emission intensity at the
maximum wavelength (&) and [h]222 (%). (B) Spectral diagram of pH-
induced equilibrium unfolding of YHKB, reporting on F340 versus [h]222.
doi:10.1371/journal.pone.0016075.g002
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amorphous after 5 and 30 minutes (Fig. 5A, B). After 2 h
incubation, small structures with a height between 3 and 7 nm
were found to coexist with assemblies of aggregates of variable size
and height between 10 and 50 nm (Fig. 5C). It is well known that
amyloid-like fibrils may form after prolonged incubation whereas
oligomers with b-sheet structure and a weak ability to bind ThT
and CR may appear much earlier [1]. AFM images were then
acquired after 60 days incubation under the same conditions.
However, fibrils were not yet apparent in the sample at this time:
large clusters of aggregates of variable size were observed, along
with smaller species with undefined morphology (Fig. 5D).
YHKB converts into a partially unfolded, potentially
amyloidogenic state in TFE
Solution conditions containing moderate concentrations of TFE
have also been widely used to form amyloid-like fibrils by both
disease-related and disease-unrelated proteins [10,12,19,21–23].
Similarly to the study performed at low pH, we first acquired far-
UV CD and fluorescence spectra in the presence of various
concentrations of TFE, ranging from 0 to 45% (v/v) at pH 5.5.
The intrinsic fluorescence of YHKB was found to decay rapidly
with TFE concentration, due to the ability of TFE to quench
dramatically tryptophan and tyrosine fluorescence. By contrast,
the far-UV CD spectra were found to be similar from 0 to 15% (v/
v) TFE, decrease in intensity at 20–26% (v/v) TFE and then
increase dramatically to reach the appearance typical of an a-
helical-enriched conformational state at TFE concentrations
higher than 40%. The plot of [h]222 versus TFE concentration
allowed this behavior to be clearly observed (Fig. 6). The first
transition causing a decrease of the CD signal at 20–26% (v/v)
TFE is due to aggregation (see below), whereas the second
transition is likely to arise from the conversion of the protein into a
monomeric a-helical conformational state.
Cyclodextrins are potential protein folding aids [35]. Their
effect on protein folding has been attributed to the ability of these
cyclic compounds to suppress protein aggregation [36]. The TFE
titration was therefore repeated in the presence of a-cyclodextrin
(Fig. 6). The transition from the native to the aggregated state was
abolished, whereas the second transition to a a-helical enriched
state was found to occur at higher TFE concentrations (Fig. 6).
This result indicates that the conversion of native YHKB into a
TFE-induced partially unfolded state is, to a good approximation,
a two-state process in the absence of aggregation.
TFE-denatured YHKB converts into aggregates with b-
sheet structure, weak ThT- and CR-binding
To promote aggregation of YHKB, the protein was incubated
at a concentration of 0.1 mg/ml in 50 mM acetate buffer, pH 5.5
and 25uC, in 30% (v/v) TFE. After 5 minutes the far-UV CD
spectrum is typical of b-sheet structure, indicating the early
accumulation of aggregates (Fig. 7A). Later, the far-UV CD
spectrum decreased in intensity, suggesting the appearance of
larger aggregates (Fig. 7A). The YHKB aggregates grown under
Figure 3. Far-UV CD spectra of native YHKB in 50 mM
phosphate buffer, pH 7.0 (&), in 20 mM TFA, pH 1.7 without
salts (%), in 20 mM TFA, pH 1.7 with 360 mM NaCl after 5 min
(m) and under the same conditions after 120 min (D).
doi:10.1371/journal.pone.0016075.g003
Figure 4. ThT and CR binding of YHKB aggregates at low pH.
(A) ThT fluorescence emission spectra obtained after addition of YHKB
samples pre-incubated at pH 1.7, 360 mM NaCl for 5, 30, 60 and 120
minutes. All spectra were obtained after subtraction of the correspond-
ing spectra obtained with ThT in the absence of YHKB. The spectrum of
ThT alone and that obtained after addition of the native protein are also
shown for comparison. (B) Difference absorbance spectra of CR obtained
with YHKB samples pre-incubated as described in panel (A). In each
case, the difference spectrum was obtained by subtracting the spectra
acquired for the protein alone and for CR alone from the spectrum
recorded for the protein in the presence of CR.
doi:10.1371/journal.pone.0016075.g004
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the same conditions for 2 hours were also analysed by X-ray
diffraction. The fibril X-ray diffraction pattern was consistent with
the cross-b conformation (Fig. 7B). In particular, the diffraction
pattern shows a strong reflection around 4.6 A˚, corresponding to
the hydrogen bonding distance between consecutive b-strands in
b-sheets, and a strong reflection around 10 A˚, corresponding to
the face-to-face distance of the b-sheets in the aggregates (Fig. 7B).
The protein samples incubated under these conditions were also
analyzed at various time intervals using the ThT and CR assays,
similarly to the analysis performed at low pH. Significant increases
in both the ThT fluorescence intensity and CR absorbance at
540 nm were observed after 5 minutes (Fig. 8). After 30 minutes
both peaks decreased in intensity, with further decreases occurring
after 60 and 120 minutes (Fig. 8).
The aggregates formed by YHKB in the presence of TFE
are not typical amyloid
The YHKB samples incubated at pH 5.5 in the presence of
30% (v/v) TFE were analyzed using TM-AFM. After 5 minutes
the aggregates appeared to consist of thin fibrils with height
between 2.2 and 2.7 nm, merging into large sheet-like structures
(Fig. 9A). These species were found to coexist with globular
structures with a height ranging from 5 to 10 nm (Fig. 9A). After
30 minutes large bundles with undefined morphology were present
(Fig. 9B). After 1 hour incubation the aggregates appeared to
consist of fibrils with a tubular morphology and a height of
7.060.2 nm (Fig. 9C). Nevertheless, these products had irregular
width and appeared to branch into distinct tubular structures at
many branching points. In addition, no regular twist was evident,
as generally observed for amyloid fibrils. Another peculiar
morphological feature was the presence of thinner fibril segments,
4.060.2 nm high, deposited on top of the tubular structures and
running perpendicular to them (Fig. 9C). These structures were
not found to be stable and reorganized further after 1 additional
hour into a very tight network of irregular aggregates with variable
width (Fig. 9D). Overall, similarly to the analysis performed at low
pH, YHKB aggregation was very rapid in the presence of TFE,
but resulted in structures that were unstable and morphologically
different from regular amyloid-like fibrils. A difference between
the two sets of conditions is that formation of aggregates with b-
sheet structure and a significant, albeit weak, ability to bind ThT
and CR was more rapid in the presence of TFE than that
occurring at low pH.
The aggregates formed by YHKB in the two sets of
conditions cause cellular dysfunction
Both the aggregates formed at low pH without TFE and in the
presence of 30% (v/v) TFE at pH 5.5 were transferred to a
physiological medium and the resulting suspensions were added to
the cell culture media of SH-SY5Y cells at a concentration of
2 mM (all concentrations refer to monomer concentration). The
ability of the resulting aggregates to cause cellular dysfunction was
assessed by performing the MTT reduction test [37]. Native
YHKB did not cause any detectable decrease in the ability of cells
to reduce MTT relative to untreated cells (Fig. 10). By contrast,
the aggregates formed under both conditions studied here were
found to cause a significant decrease in MTT reduction at all time
points (Fig. 10). The toxicity of the aggregates pre-incubated at low
pH was lost upon prolonged incubation under the same conditions
(Fig. 10). We cannot assess whether the observed toxicity arises
from the insoluble aggregates or soluble oligomers, either present
in the sample or dissociating from the insoluble aggregates. This
analysis would require further study which is beyond the scope of
the present manuscript.
Discussion
The analysis carried out here clearly indicates a remarkable
difference between proteins forming amyloid deposits in human
pathologies (or intracellular inclusions with related structural
characteristics) and proteins forming deposits of a different nature
in human diseases. Proteins forming non-amyloid deposits are
bigger in size, suggesting a high tendency to aggregate coupled to a
low propensity to form real amyloid fibrils for such proteins. To
Figure 5. TM-AFM images (height data) of YHKB aggregates
obtained in 20 mM TFA, 360 mM NaCl, pH 1.7. In each frame the
corresponding aggregation time t is reported. Scan size 1 mm; Z range
20 nm (A–C) and 30 nm (D).
doi:10.1371/journal.pone.0016075.g005
Figure 6. TFE-induced unfolding of YHKB monitored by [h]222
in the absence (&) and/or presence (%) of 1 mM a-cyclodex-
trin.
doi:10.1371/journal.pone.0016075.g006
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investigate the behavior of a sample protein with a size
intermediate between the two populations, we have studied the
in vitro aggregation process of YHKB, a fairly large protein having
486 residues and a molecular weight of 55 kDa. In order to force
YHKB into amyloid-like aggregate formation, we have incubated
this protein system in two distinct experimental conditions. These
conditions have been previously found to be effective in converting
globular proteins into amyloid-like fibrils, for both systems
associated with amyloid-related pathologies [13–16,18,19] and
model proteins with no link to protein deposition disease [9–
12,17,20–23].
Neither condition was effective in converting YHKB into typical
amyloid-like fibrils. The pH and TFE titrations indicated that
YHKB unfolds into partially folded species under both conditions,
indicating that the employed solution media were sufficient to
promote partial unfolding of the protein, a circumstance that is
ideal for amyloid fibril formation [29]. However, inspection with
AFM of the protein samples aged in such media did not show a
morphology typical of regular amyloid fibrils. At low pH in the
presence of salts, the aggregates were either globular or
amorphous. Even after prolonged incubation they appeared as
large aggregates coexisting with small species with undefined
morphology. By contrast, incubation of YHKB in the presence of
TFE produced, after just five minutes, thin fibrils merging into
wide sheets. After 1 hour, large tubular structures were present.
These branched at many points, had an irregular width and no
regular twist and were apparently surmounted by thinner fibrils
running perpendicular to them. These structures were not stable
and converted into a tight network of large structures of variable
width after 1 additional hour. All these traits are not reminiscent of
regular amyloid fibrils.
Figure 7. Far-UV CD and X-ray diffraction analysis of YHKB
aggregates in TFE. (A) Far-UV CD spectra of native YHKB in 50 mM
phosphate buffer, pH 7.0 (&), in 50 mM acetate buffer, pH 5.5 with
30% (v/v) TFE after 5 minutes (m), 30 minutes (%), 60 minutes (¤) and
120 minutes (D). (B) X-ray diffraction diagram of YHKB aggregates
grown in 50 mM acetate buffer, pH 5.5 with 30% (v/v) TFE for 120
minutes. The diagram was collected on sedimented aggregates and
shows the characteristic cross-b spacings at 4.6 and 10 A˚.
doi:10.1371/journal.pone.0016075.g007
Figure 8. ThT and CR binding of YHKB aggregates in TFE. (A)
ThT fluorescence emission spectra obtained after addition of YHKB
samples pre-incubated at pH 5.5, 30% (v/v) TFE for 5, 30, 60 and 120
minutes. All spectra were obtained after subtraction of the correspond-
ing spectra obtained with ThT in the absence of YHKB. The spectrum of
ThT alone and the spectrum obtained after addition of the native
protein are also shown for comparison. (B) Difference absorbance
spectra of CR obtained with YHKB samples pre-incubated as described
in panel (A). In each case, the difference spectrum was obtained by
subtracting the spectra acquired for the protein alone and for CR alone
from the spectrum recorded for the protein in the presence of CR.
doi:10.1371/journal.pone.0016075.g008
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Despite the fact that the aggregates of YHKB did not have a
morphology and stability typical of amyloid fibrils, YHKB
aggregation appeared to be extremely rapid under both condi-
tions. Species with b-sheet structure and a weak, yet significant,
ability to bind ThT and CR were apparent after just 5 minutes
incubation, indicating a significant tendency to form b-pleated
Figure 9. TM-AFM images (height data) of YHKB aggregates obtained in 30% (v/v) TFE, 50 mM acetate buffer, pH 5.5. In each frame
the corresponding aggregation time t is reported. Scan size 1 mm; Z range 10 nm (A, B), 30 nm (C) and 20 nm (D).
doi:10.1371/journal.pone.0016075.g009
Figure 10. Cytotoxicity of YHKB aggregates. Cell viability was determined by the MTT reduction test in SH-SY5Y cells exposed to 2 mM native
YHKB (bar 1), YHKB aggregates incubated for 5, 30 and 120 min in 30% (v/v) TFE at pH 5.5 (bars 2–4), YHKB aggregates incubated for 5 min, 30 min,
120 min and 1 month at pH 1.7, 360 mM NaCl (bars 5–8). The reported values are representative of two independent experiments, each carried out
four times.
doi:10.1371/journal.pone.0016075.g010
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aggregates in both media. Analysis carried out in TFE with X-ray
diffraction confirmed the presence of cross-b structure. Such b-
structured aggregates were also biologically harmful as their
addition to the extracellular media of cultured human SH-SY5Y
cells impaired cell viability to a significant extent.
Hence, YHKB can still aggregate under the conditions
investigated here, as the protein is partially unfolded and the
experimental media do not prevent formation of non-covalent
bonds, which is an essential pre-requisite for protein aggregation to
occur. Aggregation resulted in the formation of b-sheet structure,
but not into well defined amyloid fibrils in this case, as it was found
for many relatively small proteins under identical conditions [9–
23]. It thus appears that the small propensity found for large
proteins to form amyloid deposits in vivo under pathological
conditions can be reproduced in the test tube, suggesting that such
a behavior is an intrinsic characteristic of the big size of such
proteins.
Can an explanation for such an inverse correlation between
protein size and amyloid propensity be provided? The presence of
a partially unfolded, multidomain protein does not allow the
protein to form ordered amyloid fibrils as each single protein
molecule can form a variety of contacts with other similarly
unfolded molecules. This inherent self-assembly capacity may
inhibit formation of regular, ordered and long structures and result
rather into either amorphous structures, large and undefined
sheets or branching tubular structures. The AFM images obtained
in the presence of TFE after 1 hour are particular suggestive in
this regard (Fig. 9C). The apparent tubular fibrils appear large in
width, indicating that an extended portion of each protein
molecule may form a variety of intermolecular contacts expanding
the section area of the apparent fibril. Moreover, the tubular
structures are branched at many points, raising the possibility that
individual YHKB molecules can propagate more than one fibril
type by multiple interactions with distinct YHKB molecules, each
promoting formation of a new tubular structure. In addition, in the
AFM images the tubular species seem to give rise to other fibrils,
budding from them and appearing to be deposited on top of the
former, possibly a manifestation of the three-dimensionality of
fibril branching and propagation. However, despite such a high
degree of polymorphism, the ability of forming aggregates with a
cross-b structured core is still retained.
Overall, the ability to bind ThT and CR, albeit weak, the
presence of a significant amount of b-sheet structure, as detected
with far-UV CD and X-ray fiber diffraction, and the tendency to
give rise to structures vaguely similar to fibrils suggest that the
YHKB aggregates explored here have the germ of amyloid
structure, but the large size of the protein prevents them from
acquiring the order and regular structure typical of real amyloid
fibrils.
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